STOCK TITAN

Paysign Inc Stock Price, News & Analysis

PAYS Nasdaq

Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.

Paysign, Inc. (NASDAQ: PAYS) is a fintech and healthcare-focused company whose news flow centers on patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries. News about PAYS often highlights developments in its pharma patient affordability business, plasma donor compensation programs and the performance of its card-based payment platform.

Company press releases frequently cover quarterly financial results, where Paysign reports on total revenues, plasma revenue, pharma patient affordability revenue, gross profit, operating expenses, EBITDA and Adjusted EBITDA. These updates also describe trends in plasma center counts, the number of active pharma patient affordability programs, processed claims and the mix of revenue between plasma, pharma patient affordability and other prepaid and incentive programs.

Another recurring theme in Paysign news is the expansion and refinement of its patient affordability solutions. The company has discussed the growth of pharmaceutical copay programs, the adoption of its Dynamic Business Rules technology to address copay maximizers, and the scale of patient and client savings associated with these programs. Announcements have also described the opening of a patient service support center to increase support capacity for the patient affordability business.

Paysign news items also include participation in investor conferences, board and leadership updates and information about engagement and management platforms for life sciences. For investors, analysts and industry participants, the PAYS news page provides a centralized view of earnings releases, operational milestones, program expansions and corporate governance developments tied to the company’s fintech healthcare ecosystem.

Users interested in PAYS can use this news feed to review historical announcements on plasma and pharma program growth, cardholder and program metrics, litigation and settlement updates, and the company’s commentary on its strategic focus within payment processing and healthcare-related markets.

Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) announced its participation at the Ladenburg Thalmann Technology Expo in New York City on April 27, 2023, at 2:30 p.m. EDT. The Expo will showcase management presentations from around 50 technology firms, covering various sectors such as media, software, and hardware.

Paysign, headquartered in Henderson, Nevada, specializes in prepaid card programs and integrated payment services, enhancing operational efficiency for clients in diverse industries, including healthcare and retail.

Investors interested in attending can contact the Expo organizers via email at techexpo@ladenburg.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.83%
Tags
conferences
-
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) will discuss its first quarter 2023 earnings on May 10, 2023, at 5:00 p.m. Eastern. The company is recognized for its prepaid card programs, patient affordability offerings, and digital banking services. Participants can join by dialing 877.407.2988 (U.S.) or +1.201.389.0923 (International). A replay will be available until August 10, 2023. Paysign focuses on customized payment solutions across various sectors, aiming to enhance operational efficiency and client loyalty. Incorporated in 1995 and based in Nevada, Paysign continues to innovate in digital payout solutions and payment processing for businesses and governments, enhancing revenue and reducing costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
conferences earnings
-
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) announced its financial results for 2022, reporting total revenues of $38.0 million, a 29% increase year-over-year. The company achieved net income of $1.0 million, or $0.02 per diluted share, with Adjusted EBITDA rising 175% to $5.5 million. The fourth quarter reflected total revenues of $10.6 million, a 21% increase, alongside net income of $0.7 million. The Board authorized a $5 million share repurchase program, highlighting confidence in future opportunities, supported by the addition of 78 new plasma donation centers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.83%
Tags
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) has authorized a new stock repurchase program of up to $5,000,000 for its common stock, effective immediately and expected to conclude within 36 months. This initiative reflects the board and management's confidence in the company's operating results and growth strategy aimed at enhancing shareholder value. The repurchase will occur through open market transactions, private negotiations, or other means, with the timing and number of shares dependent on market conditions and liquidity needs. This program is intended to bolster investor confidence and potentially impact the stock price positively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.83%
Tags
buybacks
-
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) will announce its fourth quarter and annual earnings for 2022 on March 21, 2023 at 5:00 p.m. Eastern time. The company specializes in prepaid card programs and integrated payment solutions, serving various sectors including healthcare and retail. Investors can join the call via a U.S. dial-in or through a webcast. A replay will be available until June 21, 2023. Paysign's focus on innovative payment solutions aims to enhance operational efficiency and customer loyalty. For more information, visit paysign.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.79%
Tags
conferences earnings
-
Rhea-AI Summary

Paysign has partnered with EvoShare to enhance the Paysign Pays Cashback Rewards program. This collaboration introduces additional cash back opportunities for cardholders, allowing them to earn rewards on purchases made at over 10,000 local restaurants and online stores. The new features include offers from more retailers and a browser extension for instant notifications of cash back deals. This initiative is free for all Paysign cardholders, providing them with seamless access to enhanced savings benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.97%
Tags
partnership
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) will present at the D.A. Davidson 2022 Fintech and Payments Spotlight Conference on December 8, 2022, in New York City. The company will engage in one-on-one meetings, panel discussions, and networking activities. As a provider of prepaid card programs and digital banking services, Paysign continually focuses on innovative payment solutions for various industries. Investors can learn more and register for the conference here.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
conferences
-
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) will present virtually at the Ladenburg Thalmann Virtual Technology Expo on December 7, 2022, at 3:30 p.m. EST. The company specializes in prepaid card programs and digital banking solutions. Investors interested in attending or scheduling a meeting can register via the event page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
conferences
-
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) will present at The Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference on December 1, 2022. The event will take place at the New York Athletic Club, offering a platform for emerging growth companies to connect with institutional investors. Paysign is set to participate in one-on-one meetings throughout the day. Investors interested in scheduling meetings can register online. The company is known for providing prepaid card programs and integrated payment processing services across various industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
conferences
Rhea-AI Summary

Paysign, Inc. (NASDAQ: PAYS) reported third-quarter 2022 revenues of $10.6 million, up 36% from the previous year. Net income reached $0.85 million, translating to diluted EPS of $0.02. The firm added 13 plasma donation centers in Q3, totaling 450 centers. Gross dollar load volume rose 57.6%, while purchase volume climbed 58.6%. Adjusted EBITDA stood at $1.9 million, reflecting solid operational performance. Looking ahead, total revenue for 2022 is projected between $38.15 million and $38.35 million, indicating 29-30% growth over 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.67%
Tags

FAQ

What is the current stock price of Paysign (PAYS)?

The current stock price of Paysign (PAYS) is $3.39 as of February 15, 2026.

What is the market cap of Paysign (PAYS)?

The market cap of Paysign (PAYS) is approximately 186.6M.
Paysign Inc

Nasdaq:PAYS

PAYS Rankings

PAYS Stock Data

186.60M
34.72M
36.52%
36.46%
2.12%
Software - Infrastructure
Services-business Services, Nec
Link
United States
HENDERSON

PAYS RSS Feed